Biochemical, pathologic and behavioral analysis of a mouse model of glutaric acidemia type I.

No abstract is available for this paper.

• Publication year

  2002

• Venue

  Human Molecular Genetics

• Publication date

  2002-02-15

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1093/HMG/11.4.347PMID 11854167
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Neuropathology in glutaric acidaemia type 1

  2004influential reference
• Neurological abnormalities in a knock-in mouse model of Huntington's disease.

  2001influential reference
• The Metabolic and Molecular Bases of Inherited Disease

  2001cited by this paper
• Mice with Mutations in the Mahogany Gene Atrn Have Cerebral Spongiform Changes

  2001cited by this paper
• Glutaryl-CoA Dehydrogenase Deficiency in Spain: Evidence of Two Groups of Patients, Genetically, and Biochemically Distinct

  2000cited by this paper
• Age at symptom onset predicts severity of motor impairment and clinical outcome of glutaric acidemia type 1.

  2000cited by this paper
• Analysis of the expression of murine glutaryl-CoA dehydrogenase: in vitro and in vivo studies.

  2000influential reference
• 3-Hydroxyglutaric and glutaric acids are neurotoxic through NMDA receptors in vitro

  1999cited by this paper
• Glutaric aciduria type I: Pathomechanisms of neurodegeneration

  1999cited by this paper
• Characterization of Progressive Motor Deficits in Mice Transgenic for the Human Huntington’s Disease Mutation

  1999influential reference
• Glutaryl‐CoA dehydrogenase mutations in glutaric acidemia (type I): Review and report of thirty novel mutations

  1998cited by this paper
• Diagnosis and management of glutaric aciduria type I

  1998influential reference
• Nerve cell lesions caused by 3-hydroxyglutaric acid: A possible mechanism for neurodegeneration in glutaric acidaemia I

  1997cited by this paper
• Mitochondrial toxin 3-nitropropionic acid produces startle reflex abnormalities and striatal damage in rats that model some features of Huntington's disease.

  1997cited by this paper
• Clinical course, early diagnosis, treatment, and prevention of disease in glutaryl-CoA dehydrogenase deficiency.

  1996cited by this paper
• Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice.

  1996cited by this paper
• Impaired prepulse inhibition of acoustic and tactile startle response in patients with Huntington's disease.

  1995cited by this paper
• Prepulse inhibition of the startle response in mice: relationship to hearing loss and auditory system plasticity.

  1994cited by this paper
• Laboratory methods in histotechnology

  1992cited by this paper
• Striatal degeneration and spongy myelinopathy in glutaric acidemia.

  1992influential reference
• Targeted disruption of the c-src proto-oncogene leads to osteopetrosis in mice.

  1991cited by this paper
• Hypothesis: A Role for Quinolinic Acid in the Neuropathology of Glutaric Aciduria Type I

  1987cited by this paper
• A beta-galactosidase hybrid protein targeted to nuclei as a marker for developmental studies.

  1987cited by this paper
• Mammalian metabolism of glutaric acid.

  1969cited by this paper
• Neuropathology

  1926cited by this paper

• The neuropathological mechanisms underlying the inborn errors of lysine metabolism.

  2026cites this paper
• A novel splice GCDH variant and analysis of splicing variants in glutaric aciduria type I

  2026cites this paper
• Brain morphometry and cognition in late-onset glutaric aciduria type 1: scoping review and novel insights from a case report

  2026cites this paper
• Therapeutic AASS inhibition by AAV-miRNA rescues glutaric aciduria type I severe phenotype in mice

  2025cites this paper
• Structure Elucidation for MALDI Mass Spectrometry Imaging Using Infrared Ion Spectroscopy

  2025cites this paper
• Neuroprotective effects of L-carnitine towards oxidative stress and inflammatory processes: a review of its importance as a therapeutic drug in some disorders

  2025cites this paper
• Neurocognitive characterization and academic impact in pediatric patients belonging to the national registry of GA-1

  2025cites this paper
• Novel Taxol-Derivative, STO-1, Induces Selective Anti-Tumor Immunity and Sustained Remission of Glioblastoma Without Triggering Autoimmune Reactions

  2025cites this paper
• Cerebral White Matter Alterations Associated With Oligodendrocyte Vulnerability in Organic Acidurias: Insights in Glutaric Aciduria Type I

  2024cites this paper
• Impairment of neuromotor development and cognition associated with histopathological and neurochemical abnormalities in the cerebral cortex and striatum of glutaryl-CoA dehydrogenase deficient mice.

  2024cites this paper
• Systemic delivery of AAV-GCDH ameliorates HLD-induced phenotype in a glutaric aciduria type I mouse model

  2024cites this paper
• Morphological evidence of the protective effects of a synthetic chalcone against the striatal myelin damage induced by glutaric acid

  2023cites this paper
• Rescue of glutaric aciduria type I in mice by liver-directed therapies

  2023cites this paper
• Modeling Glutaric Aciduria Type I in human neuroblastoma cells recapitulates neuronal damage that can be rescued by gene replacement

  2023cites this paper
• Disturbance of Mitochondrial Dynamics, Endoplasmic Reticulum–Mitochondria Crosstalk, Redox Homeostasis, and Inflammatory Response in the Brain of Glutaryl-CoA Dehydrogenase-Deficient Mice: Neuroprotective Effects of Bezafibrate

  2022cites this paper
• Treatment of glutaric aciduria type I (GA-I) via intracerebroventricular delivery of GCDH

  2022influential citation
• 3-Hydroxyglutaric Acid as a Neurotoxin

  2021cites this paper
• Glutaric aciduria type 1

  2021cites this paper
• Nuclear Factor Erythroid-2-Related Factor 2 Signaling in the Neuropathophysiology of Inherited Metabolic Disorders

  2021cites this paper
• The first knock-in rat model for glutaric aciduria type I allows further insights into pathophysiology in brain and periphery.

  2021cites this paper
• Functions and Mechanisms of Lysine Glutarylation in Eukaryotes

  2021cites this paper
• Protective effects of L-carnitine on behavioral alterations and neuroinflammation in striatum of glutaryl-COA dehydrogenase deficient mice.

  2021cites this paper
• Increased susceptibility to quinolinic acid‐induced seizures and long‐term changes in brain oscillations in an animal model of glutaric acidemia type I

  2021cites this paper
• Glutaric Acid Neurotoxicity: Mechanisms and Actions

  2021cites this paper
• A knock-in rat model unravels acute and chronic renal toxicity in glutaric aciduria type I.

  2021cites this paper
• Glutaric acidemia type 1: Treatment and outcome of 168 patients over three decades.

  2020cites this paper
• Glutaric aciduria type 3 is a naturally occurring biochemical trait in inbred mice of 129 substrains

  2020cites this paper
• Lipopolysaccharide-Elicited Systemic Inflammation Induces Selective Vulnerability of Cerebral Cortex and Striatum of Developing Glutaryl-CoA Dehydrogenase Deficient (Gcdh−/−) Mice to Oxidative Stress

  2020cites this paper
• Deletion of 2‐aminoadipic semialdehyde synthase limits metabolite accumulation in cell and mouse models for glutaric aciduria type 1

  2020cites this paper
• Audiological and otologic manifestations of glutaric aciduria type I

  2020cites this paper
• DHTKD1 and OGDH display substrate overlap in cultured cells and form a hybrid 2-oxo acid dehydrogenase complex in vivo.

  2020cites this paper
• Elevated levels of BDNF and cathepsin‐d as possible peripheral markers of neurodegeneration in plasma of patients with glutaric acidemia type I

  2020cites this paper
• Disruption of mitochondrial functions and oxidative stress contribute to neurologic dysfunction in organic acidurias.

  2020cites this paper
• Neurological manifestations of organic acidurias

  2019cites this paper
• Hereditary diseases of coenzyme A thioester metabolism.

  2019cites this paper
• Knockout of the non-essential gene SUGCT creates diet-linked, age-related microbiome disbalance with a diabetes-like metabolic syndrome phenotype

  2019cites this paper
• An explanation for metabolite excretion in high- and low-excretor patients with glutaric acidemia type 1.

  2019cites this paper
• Lysine glutarylation in human sperm is associated with progressive motility.

  2019cites this paper
• l-Carnitine prevents oxidative stress in striatum of glutaryl-CoA dehydrogenase deficient mice submitted to lysine overload.

  2019cites this paper
• DHTKD1 and OGDH display in vivo substrate overlap and form a hybrid ketoacid dehydrogenase complex

  2019cites this paper
• Inborn errors of mitochondrial acyl-coenzyme a metabolism: acyl-CoA biology meets the clinic.

  2019cites this paper
• Pathogenesis of brain damage in glutaric acidemia type I: Lessons from the genetic mice model

  2019influential citation
• Acute lysine overload provokes marked striatum injury involving oxidative stress signaling pathways in glutaryl-CoA dehydrogenase deficient mice.

  2019cites this paper
• Altered Redox Homeostasis in Branched-Chain Amino Acid Disorders, Organic Acidurias, and Homocystinuria

  2018cites this paper
• Disease-Linked Glutarylation Impairs Function and Interactions of Mitochondrial Proteins and Contributes to Mitochondrial Heterogeneity.

  2018cites this paper
• Long Lasting High Lysine Diet Aggravates White Matter Injury in Glutaryl-CoA Dehydrogenase Deficient (Gcdh−/−) Mice

  2018cites this paper
• Malignant brain tumors in patients with glutaric aciduria type I.

  2018cites this paper
• Arachnoid Cysts in Glutaric Aciduria Type I (GA-I)

  2018cites this paper
• Experimental Evidence that In Vivo Intracerebral Administration of L-2-Hydroxyglutaric Acid to Neonatal Rats Provokes Disruption of Redox Status and Histopathological Abnormalities in the Brain

  2018cites this paper
• Impairment of GABAergic system contributes to epileptogenesis in glutaric acidemia type I

  2017cites this paper
• Higher Vulnerability of Menadione-Exposed Cortical Astrocytes of Glutaryl-CoA Dehydrogenase Deficient Mice to Oxidative Stress, Mitochondrial Dysfunction, and Cell Death: Implications for the Neurodegeneration in Glutaric Aciduria Type I

  2017cites this paper
• Induction of Neuroinflammatory Response and Histopathological Alterations Caused by Quinolinic Acid Administration in the Striatum of Glutaryl-CoA Dehydrogenase Deficient Mice

  2017cites this paper
• Elevated glutaric acid levels in Dhtkd1-/Gcdh- double knockout mice challenge our current understanding of lysine metabolism.

  2017cites this paper
• Immunolocalization of glutaryl-CoA dehydrogenase (GCDH) in adult and embryonic rat brain and peripheral tissues.

  2017cites this paper
• Finding Treatments for Genetic Metabolic Disease

  2016cites this paper
• Astrocyte Dysfunction in Developmental Neurometabolic Diseases.

  2016cites this paper
• Chapter 27 – Mouse Models of Dystonia

  2015cites this paper
• Inborn Errors of Metabolism: Advances in Diagnosis and Therapy.

  2015cites this paper
• In Vivo NMR Studies of the Brain with Hereditary or Acquired Metabolic Disorders

  2015cites this paper
• A role of astrocytes in mediating postnatal neurodegeneration in Glutaric acidemia‐type 1

  2015cites this paper
• Experimental evidence that bioenergetics disruption is not mainly involved in the brain injury of glutaryl-CoA dehydrogenase deficient mice submitted to lysine overload.

  2015cites this paper
• Proteomic and Biochemical Studies of Lysine Malonylation Suggest Its Malonic Aciduria-associated Regulatory Role in Mitochondrial Function and Fatty Acid Oxidation*

  2015cites this paper
• Striatal neuronal death mediated by astrocytes from the Gcdh-/- mouse model of glutaric acidemia type I.

  2015cites this paper
• Multifactorial modulation of susceptibility to l-lysine in an animal model of glutaric aciduria type I.

  2015cites this paper
• Increased Glutamate Receptor and Transporter Expression in the Cerebral Cortex and Striatum of Gcdh -/- Mice: Possible Implications for the Neuropathology of Glutaric Acidemia Type I

  2014cites this paper
• Metabolism leaves its mark on the powerhouse: recent progress in post-translational modifications of lysine in mitochondria

  2014cites this paper
• Lysine glutarylation is a protein posttranslational modification regulated by SIRT5.

  2014cites this paper
• Disturbance of the glutamatergic system by glutaric acid in striatum and cerebral cortex of glutaryl-CoA dehydrogenase-deficient knockout mice: possible implications for the neuropathology of glutaric acidemia type I.

  2014cites this paper
• Metabolic disturbances in diseases with neurological involvement.

  2014cites this paper
• Mechanism of metabolic stroke and spontaneous cerebral hemorrhage in glutaric aciduria type I

  2014cites this paper
• Avaliação da homeostase energética em vários tecidos e histopatologia cerebral em camundongos nocaute para a enzima glutaril-CoA desidrogenase

  2014cites this paper
• Glutaric Acid-Mediated Apoptosis in Primary Striatal Neurons

  2014cites this paper
• Acute lysine overload provokes protein oxidative damage and reduction of antioxidant defenses in the brain of infant glutaryl-CoA dehydrogenase deficient mice: a role for oxidative stress in GA I neuropathology.

  2014cites this paper
• Effects of Targeted Suppression of Glutaryl-CoA Dehydrogenase by Lentivirus-Mediated shRNA and Excessive Intake of Lysine on Apoptosis in Rat Striatal Neurons

  2013cites this paper
• Current concepts in organic acidurias: understanding intra- and extracerebral disease manifestation

  2013cites this paper
• Acute renal proximal tubule alterations during induced metabolic crises in a mouse model of glutaric aciduria type 1.

  2013cites this paper
• Disruption of brain redox homeostasis in glutaryl-CoA dehydrogenase deficient mice treated with high dietary lysine supplementation.

  2013cites this paper
• White Matter Injury Induced by Perinatal Exposure to Glutaric Acid

  2013cites this paper
• Neurodevelopmental and cognitive behavior of glutaryl-CoA dehydrogenase deficient knockout mice.

  2013cites this paper
• Ammonium Accumulation and Cell Death in a Rat 3D Brain Cell Model of Glutaric Aciduria Type I

  2013cites this paper
• N-Acetylcysteine Prevents Spatial Memory Impairment Induced by Chronic Early Postnatal Glutaric Acid and Lipopolysaccharide in Rat Pups

  2013cites this paper
• Induction of oxidative stress in brain of glutaryl-CoA dehydrogenase deficient mice by acute lysine administration.

  2012cites this paper
• Reduction of Na+, K+-ATPase activity and expression in cerebral cortex of glutaryl-CoA dehydrogenase deficient mice: a possible mechanism for brain injury in glutaric aciduria type I.

  2012cites this paper
• Complementary dietary treatment using lysine-free, arginine-fortified amino acid supplements in glutaric aciduria type I - A decade of experience.

  2012cites this paper
• Caspase-3 mediates apoptosis of striatal cells in GA I rat model

  2012cites this paper
• Caspase-3 mediates apoptosis of striatal cells in GA I rat model

  2012cites this paper
• Marked reduction of Na(+), K(+)-ATPase and creatine kinase activities induced by acute lysine administration in glutaryl-CoA dehydrogenase deficient mice.

  2012cites this paper
• Glutaric aciduria type 1

  2012cites this paper
• Glutaric aciduria type I: A translational approach to an enigmatic disease

  2011cites this paper
• Therapeutic modulation of cerebral L-lysine metabolism in a mouse model for glutaric aciduria type I.

  2011cites this paper
• Safety, efficacy and physiological actions of a lysine-free, arginine-rich formula to treat glutaryl-CoA dehydrogenase deficiency: focus on cerebral amino acid influx.

  2011cites this paper
• Glutaric Aciduria Type 1 Metabolites Impair the Succinate Transport from Astrocytic to Neuronal Cells*

  2011cites this paper
• The unsolved puzzle of neuropathogenesis in glutaric aciduria type I.

  2011cites this paper
• A influência do processo inflamatório nas convulsões e no déficit cognitivo induzidos pelo ácido glutárico em ratos jovens

  2011cites this paper
• Mouse model of encephalopathy and novel treatment strategies with substrate competition in glutaric aciduria type I.

  2010cites this paper
• Use of guidelines improves the neurological outcome in glutaric aciduria type I

  2010cites this paper
• Induction of S100B secretion in C6 astroglial cells by the major metabolites accumulating in glutaric acidemia type I

  2010influential citation
• Kinetic characterization of l‐[3H]glutamate uptake inhibition and increase oxidative damage induced by glutaric acid in striatal synaptosomes of rats

  2009cites this paper
• Dynamic changes of striatal and extrastriatal abnormalities in glutaric aciduria type I.

  2009cites this paper
• Transport and distribution of 3-hydroxyglutaric acid before and during induced encephalopathic crises in a mouse model of glutaric aciduria type 1.

  2008cites this paper